Press release
Global Radiopharmaceutical Market Comprehensive Research on Opportunity and Growth Analysis 2018-2023
Pune, India, May, 2018 /press release/- Market Research Future Published a Cooked Research Report on Global Radiopharmaceutical Research Report.Market Highlights
As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.
The global radiopharmaceutical market is expected to grow at a CAGR of 8.7% during the forecast period 2017–2023.
Avail Sample for this Report at: https://www.marketresearchfuture.com/sample_request/1650
Market Segmentation
The global radiopharmaceutical market is segmented by type, type of test, application, route of administration, and end user.
By type, it is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. Diagnostic type radiopharmaceutical is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. Therapeutic type radiopharmaceutical is further sub-segmented into beta emitters, alpha emitters, brachytherapy. SPECT radiopharmaceutical is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. PET radiopharmaceutical is further sub-segmented into F-18, Rubidium-82, and others. While, beta emitters are sub-segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. And, brachytherapy is sub-segmented into Iodine-125, Iridium-192, Cesium-131, and others.
By type of test, it is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. Whereas, a bone scan is further sub-segmented into Technetium-99m 1st, fluoride-18 2nd, and others. Myocardial Perfusion Scan, Type is sub-segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan by type is segmented into Xenon-133, Krypton-81m, and others. And, White blood cell Scan is sub-segmented into Indium-111 and others.
By application, it is segmented into oncology, cardiology, neurology, urology, and others. Oncology segment is further segmented into following applications; prostate cancer, bone cancer, breast cancer and others. Cardiology segment is further segmented into following applications; coronary artery disease, cardiomyopathy and others. Neurology segment is further segmented into following applications such as traumatic brain injury, stroke, Alzheimer’s disease and others. Urology is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.
By Route of Administration, it is segmented into oral, intravenous and others.
By End User, it is segmented into hospitals, diagnostic centers, research institutes and others.
Access Report @ https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650
Regional Analysis
The global radiopharmaceutical market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa. Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. Currently, these two regions collectively account for the largest share of the market and the trend is likely to continue over the next couple of years. Higher healthcare spending and existence a robust healthcare system system in these regions is reflecting favorably on the market. In Asia Pacific, increased focus on improving the quality of healthcare services is auguring well for market players operating in the region. During the review period, the market in the region is expected to capture a strong CAGR.
Major Players in the Radiopharmaceutical Market
Some of the key players in this market are Jubilant Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.
Enquire for discount at: https://www.marketresearchfuture.com/check-discount/1650
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Radiopharmaceutical Market Comprehensive Research on Opportunity and Growth Analysis 2018-2023 here
News-ID: 1294883 • Views: …
More Releases from MarketResearchFuture

Miglitol Market Report Size, Share, and Forecast 2032 | Novartis ,Daiichi Sankyo …
According to WGR's most recent report, the Miglitol Market 2024-2032 is anticipated to grow rapidly over the coming years. Through the process of research, consolidation, market size, overview, and review of data obtained from multiple sources, the Miglitol Market report provides a meaningful representation of the region.
In the Miglitol Market Study, you will find details about market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial…

Smart Fleet Management Market Size, Share Demand Rising Worldwide 2030
Market Outlook:
The Smart Fleet Management market is estimated to attain a valuation of USD 605.7 billion by the end of 2030, states a study by Market research Future (MRFR). Besides, the report notes that the Smart Fleet Management market is prognosticated to expand at a CAGR of 10.1% during the forecast period, 2023-2030.
Smart fleet management is experiencing significant market trends driven by advancements in technology and evolving industry needs. One…

Automotive Heat Shield Market Size, Share, Demand Trends and Forecasts to 2032
According to projections, the Automotive Heat Shield market will expand at a compound annual growth rate (CAGR) of 3.8% from USD 15825.1 million in 2021 to USD 18759.1 million in 2032. Heat shields are used to shield a device's internal components from heat produced by the core.
In the automotive industry, the heat shield is utilized to reduce the excessive heat generated by internal combustion engines. Heat shields are most frequently…

Automotive Filters Market Size, Share, Business Key Players, Forecast By 2032
The size of the automotive Automotive Filters market was estimated at USD 25.1 billion in 2022. With a compound annual growth rate (CAGR) of 3.00% over the forecast period (2023-2032), the automotive Automotive Filters market industry is expected to expand from USD 25.8 billion in 2023 to USD 32.7 billion by 2032. The main factors propelling the market's expansion are rising sales, the need for automobile Automotive Filters, and the…
More Releases for Radiopharmaceutical
Nuclear Medicine Market: Advancing Healthcare with Radiopharmaceutical Innovatio …
The Nuclear Medicine Market is undergoing a rapid transformation in 2025, driven by technological advancements, shifting consumer preferences, and an increased emphasis on sustainability. Companies are leveraging digital solutions, AI-driven analytics, and automation to enhance operational efficiency and improve customer experiences. This report provides an in-depth analysis of key market trends, growth drivers, competitive dynamics, and emerging opportunities.
Unlock Insights with a Free Sample Report @ https://www.skyquestt.com/sample-request/nuclear-medicine-market
Market Outlook and Growth…
Radiopharmaceutical/Nuclear Medicine Market Size and Trends
The radiopharmaceutical/nuclear medicine market is poised for significant expansion in the coming years. With advancements in technology, increasing disease prevalence, and a growing emphasis on personalized medicine, the market presents lucrative opportunities for stakeholders. As the healthcare landscape evolves, the integration of innovative radiopharmaceuticals into clinical practice will continue to enhance diagnostic and therapeutic outcomes, ultimately improving patient care.
The key players in the radiopharmaceutical/nuclear medicine market include Eckert & Ziegler,…
Radiopharmaceutical Market 2021 | Detailed Report
Radiopharmaceutical Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Radiopharmaceutical Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4123322
The report provides a comprehensive analysis of company profiles listed below:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
-…
Impressive Trends and Future Scope of Radiopharmaceutical Market
Radiopharmaceutical Market: Introduction
According to the report, the global radiopharmaceutical market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Some of the factors driving the radiopharmaceutical market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population, pipeline assessment of new drugs, and disease indication mortality. Shutdown of some of the…
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals.
Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
According to the…
Competition Landscape for Radiopharmaceutical Market Global Industry 2024
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024.
Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological…